2seventy bio, Inc.
TSVT
$4.95
$2.1576.79%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 50.93% | -27.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 50.93% | -27.89% | |||
| Cost of Revenue | -27.63% | -59.81% | |||
| Gross Profit | 94.72% | 70.83% | |||
| SG&A Expenses | 30.71% | -22.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.02% | -52.00% | |||
| Operating Income | 33.99% | 58.16% | |||
| Income Before Tax | -139.93% | 147.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -139.93% | 147.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -139.93% | 147.23% | |||
| EBIT | 33.99% | 58.16% | |||
| EBITDA | 36.94% | 59.87% | |||
| EPS Basic | -139.88% | 147.12% | |||
| Normalized Basic EPS | 42.57% | 63.76% | |||
| EPS Diluted | -142.24% | 144.48% | |||
| Normalized Diluted EPS | 39.45% | 65.62% | |||
| Average Basic Shares Outstanding | 0.15% | 0.22% | |||
| Average Diluted Shares Outstanding | -5.00% | 5.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
